Illumina (MIL:1ILMN) Ending Cash Position: €903 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1ILMN Illumina Inc MIL:1ILMN
46 GF Score
Price €169.36
GF Value €107.48
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Ending Cash Position?

Illumina MIL:1ILMN -0.22% 46 Ending Cash Position is €903 Mil as of Jun. 2026. GuruFocus rates MIL:1ILMN with a GF Score™ of 46/100 and a GF Value™ of €107.48 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Illumina's Ending Cash Position for the quarter that ended in Jun. 2026 was €903 Mil.

Illumina's quarterly Ending Cash Position declined from Dec. 2025 (€1,211 Mil) to Mar. 2026 (€942 Mil) and declined from Mar. 2026 (€942 Mil) to Jun. 2026 (€903 Mil).

Illumina's annual Ending Cash Position increased from Dec. 2023 (€961 Mil) to Dec. 2024 (€1,076 Mil) and increased from Dec. 2024 (€1,076 Mil) to Dec. 2025 (€1,211 Mil).

Illumina Ending Cash Position Related Terms

Illumina Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Illumina's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Ending Cash Position Chart

Illumina Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,090.32 1,898.38 961.02 1,076.29 1,210.97

Illumina Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 809.78 894.60 1,210.97 941.99 902.72
MIL:1ILMN
46GF Score
Illumina Inc MIL:1ILMN
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Illumina Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Illumina's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=962.458+248.514
=1,211

Illumina's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=945.252+-42.532
=903

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €903 Mil mean?
Illumina (MIL:1ILMN) has a Ending Cash Position of €903 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Illumina and its competitors.
Is Illumina's Ending Cash Position too high?
Illumina's current Ending Cash Position is €903 Mil. Overall, Illumina has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Illumina's Ending Cash Position compare to MTD and DGX?
Illumina's Ending Cash Position of €903 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Illumina and its competitors. Illumina's current Ending Cash Position is €903 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Illumina stock overvalued right now?
Based on GuruFocus' analysis, Illumina (MIL:1ILMN) is currently considered Significantly Overvalued. The stock's GF Value™ is €107.48, compared to a current price of €169.36 — trading 57.6% above its estimated fair value. The current Ending Cash Position is €903 Mil. Illumina's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Illumina (MIL:1ILMN), the current Ending Cash Position is €903 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Illumina (MIL:1ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of €169.36 is trading 57.6% above its estimated GF Value™ of €107.48. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for MIL:1ILMN:

  • Ending Cash Position: €903 Mil
  • GF Value™: €107.48 vs. price of €169.36 (57.6% above fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the MIL:1ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
46GF Score

Get the complete analysis for MIL:1ILMN

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€169.36
Price
€107.48
GF Value